Large Cell Lung Neuroendocrine Carcinoma

Details 52 Trials 2 Therapies

A high grade malignant neoplasm that arises from the lung and is characterized by the presence of large neuroendocrine cells. It usually has an aggressive clinical course.

parent conditions

Large Cell Neuroendocrine Carcinoma

Lung Neuroendocrine Carcinoma

child conditions

Combined Large Cell Lung Neuroendocrine Carcinoma

synonyms

LCNEC of the Lung

Lung Large Cell Neuroendocrine Carcinoma

Large Cell Lung Neuroendocrine Carcinoma

Large Cell Neuroendocrine Carcinoma of Lung

Pulmonary Large Cell Neuroendocrine Carcinoma

Large Cell Neuroendocrine Carcinoma of the Lung

Large Cell Neuroendocrine Carcinoma Lung Primary

Large Cell Lung Carcinoma with Neuroendocrine Differentiation

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

78 sites for NCT02693535

AKT1 Mutation, +128 more biomarkers

Adenocarcinoma of the Gastroesophageal Junction, +19 more conditions

abemaciclib, +23 more drugs

immunotherapy, +1 more type

A Study of LOXO-292 in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer

79 sites for NCT03157128

RET Fusion, +1 more biomarker

Adrenal Gland Pheochromocytoma, +5 more conditions

selpercatinib

targeted therapy

Neuropsychological and Behavioral Testing in Younger Patients With Cancer

142 sites for NCT00772200

Cancer

observation

Other

Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)

25 sites for NCT02628067

Deficient DNA Mismatch Repair (dMMR), +6 more biomarkers

Anal Squamous Cell Carcinoma, +18 more conditions

pembrolizumab

immunotherapy

Long-Term Follow-up Protocol for Subjects Treated With Gene-Modified T Cells

137 sites for NCT03435796

Neoplasm

engineered T-cell therapy

cellular therapy, +1 more type

A Study of Bempegaldesleukin (BEMPEG: NKTR-214) in Combination With Nivolumab in Children, Adolescents and Young Adults With Recurrent or Treatment-resistant Cancer

40 sites for NCT04730349

Cancer

bempegaldesleukin, +1 more drug

immunotherapy, +1 more type

Show 52 Trials for Large Cell Lung Neuroendocrine Carcinoma

pembrolizumab

TMB-High

Neuroendocrine Carcinoma